Avivagen Inc. announced the appointment of Mr. Ira Levy as interim CFO, effective immediately. Mr. Levy has over 15 years of experience in a wide range of high-growth, early-stage companies, both public and private, with an MBA from the Schulich School of Business in addition to his professional designation as a Chartered Accountant.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 282K | |
+11.04% | 11.41B | |
-4.29% | 5.57B | |
-1.49% | 5B | |
+1.02% | 4.4B | |
-21.31% | 2.66B | |
+1.08% | 1.85B | |
-22.67% | 1.14B | |
-20.67% | 918M | |
-16.12% | 891M |
- Stock Market
- Equities
- VIV Stock
- News Avivagen Inc.
- Avivagen Inc. Appoints Ira Levy as Interim CFO